SK Hynix spins off Solidigm for US IPO: Goldman Sachs and Morgan Stanley lead underwriting, $10 billions fundraising focuses on AI storage
SK Hynix has finalized the underwriting lineup for the U.S. IPO of its NAND flash memory subsidiary, Solidigm, choosing Goldman Sachs and Morgan Stanley as lead underwriters. The fundraising amount is approximately 10 billions USD. This marks the first time since SK Hynix acquired Intel's NAND and SSD business and established Solidigm that a clear independent capital operation path has been defined for this asset.
On October 7, according to Bloomberg, SK Hynix has selected Goldman Sachs and Morgan Stanley as the lead underwriters for Solidigm’s US IPO, which could raise about 10 billion USD. Following SK Hynix’s own record-breaking Nasdaq listing this July that raised 26.5 billion USD, the Korean memory giant is once again bringing its assets to the US public market.
This spin-off means Solidigm will be independently priced on the US stock market, focusing on AI-driven enterprise storage demand, providing investors with a publicly listed target to independently observe NAND business performance.
Against the backdrop of rising NAND prices and expanding enterprise storage demand from AI data centers, Solidigm’s independent listing becomes the latest step in the securitization of memory assets.
SK Hynix previously completed the acquisition of Intel’s NAND and SSD business and established its subsidiary Solidigm, but the capital operation path for this subsidiary had remained unclear. The selection of Goldman Sachs and Morgan Stanley as lead underwriters to push for its independent US listing marks SK Hynix’s formal move to bring its NAND business to the public market.
The core rationale for Solidigm’s independent listing is to obtain a higher valuation as an independent entity and to focus on AI-driven enterprise storage demand. NAND differs significantly from SK Hynix’s main products, HBM and DRAM, in terms of technology paths and customer structure. After listing independently, Solidigm can establish its own financing channels and directly present its enterprise storage narrative to US investors.
NAND Upcycle and the Race with Kioxia
The timing of Solidigm’s listing coincides with a NAND price upcycle.
According to TrendForce data, in Q2 2026 NAND flash prices increased by 55% to 60% quarter-on-quarter, and are expected to rise another 10% to 15% in Q3. Meanwhile, Kioxia, a Toshiba subsidiary, is also preparing for a US listing, with both leading giants in the NAND sector advancing their capital market moves simultaneously.
SK Hynix itself set a record for foreign companies’ IPOs in the US with 26.5 billion USD raised. Whether Solidigm can replicate its parent company’s market enthusiasm by raising about 10 billion USD will be the first window to observe whether the AI storage narrative can support an independent NAND valuation.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Third largest since 2008! US stocks saw single-week outflows of $11 billions, technology stocks hit hardest
Last week, institutional investors significantly sold off individual stocks, resulting in a net outflow of $11.0 billion from the U.S. stock market. Funds were mainly withdrawn from the technology sector, marking the third largest single-week outflow from individual stocks in the history of Bank of America's statistics.
Google (GOOGL.US) AI pharmaceutical company Isomorphic Labs launches new financing: Raised $2.1 billions five months ago, current round aims for a $50 billions valuation
Isomorphic Labs, a DeepMind spin-off, is in talks for new financing, with its valuation potentially reaching up to $50 billions. This comes only five months after its $2.1 billions Series B funding round.
Valuation hits a ten-year low! Barclays initiates coverage on 26 US medical technology stocks, with Stryker (SYK.US) among its top picks
Barclays analyst Christopher Pasquale on Tuesday initiated coverage on 26 US-listed medtech companies for the first time, and included Stryker (SYK.US) and Abbott (ABT.US) on the recommended list of large-cap medtech stocks.
Citigroup raises profit forecast; Australian exchange operator's stock price rises
On Thursday, shares of Australian Securities Exchange operator ASX Ltd (ASX.AX) surged to nearly a two-month high after Citi raised its annual profit outlook for the company, citing a strong first-quarter performance and predicting robust market activity to continue into the first half of the year. Details are as follows: The exchange operator's average daily trading volume in the spot market rose 16% year-on-year in September. Citi analysts noted that daily futures trading volumes climbed 44% during the month, approaching historical highs, possibly reflecting structural and cyclical factors, including interest rate prospects and changes in the bond market. Citi added that strong market activity is expected to last at least through the first half, and consequently raised ASX's annual earnings-per-share forecast by 2%. Citi pointed out, however, that corporate market activity remained subdued in September. Short-term market activity is expected to be boosted with Glencore's GLEN.L company planning a secondary listing in October and Firmus company planning an initial public offering (IPO) in October. Both Citi and UBS raised their target price for ASX from AU$60.10 and AU$64.20 to AU$61.00 and AU$65.50, respectively. Meanwhile, Goldman Sachs remains cautious about the strategy of the new CEO, Anthony Attia, and the company's potential future financial situation. Goldman Sachs is also alert to execution risks in the exchange operator's CHESS system replacement and technology modernization plans. This comes after the central bank stated in September that the company's clearing and settlement facilities had not met the bank's expectations. ASX shares closed up 3.8%, reaching their highest level in nearly two months and ranking among the top performers on the S&P/ASX 200 index.
Crypto prices
More
